A recent study published in Engineering has shed new light on the role of the protein NSUN2 in the development of cardiac ...

A year-long experiment found that even low doses of aspartame—well below current safety limits—may disrupt brain energy use ...

A new study published in Engineering reveals that NSUN2, a key protein involved in RNA modification, significantly ...

New research reveals that even low doses of aspartame are linked to heart muscle stiffening and cognitive decline, ...

A new study suggests that aspartame consumption may be linked to decreased heart and brain function. The artificial sweetener ...

Echocardiograms reveal a rapid rise in LV hypertrophy from ages 17 to 24 years, bolstering the case for primordial prevention.

A study carried out by scientists at the Centro Nacional de Investigaciones Cardiovasculares (CNIC) and led by Dr. Guadalupe Sabio has identified a key role for the MKK3/6–p38γ/δ signaling pathway in ...

After 1 year of antihypertensive therapy in the LIFE study, regression of ECG LVH by the Cornell product was present in 155 patients (26.5%); there was no significant decrease in the Cornell product ...

- First-ever data on therapeutic miR-132 inhibition in a large animal model of nonischemic heart failure with cardiac hypertrophy and fibrosis Hanover, Germany, June 24, 2021 - Cardior Pharmaceuticals ...

A developmental cause of adult-onset cardiac hypertrophy, a dangerous thickening of the heart muscle that can lead to heart failure and death, has been identified by researchers. They say that the new ...